Bynfezia Pen Injection
Product Images NDC 62756-452

Product Visual Gallery

This gallery contains 28 technical images submitted to the FDA as part of the official labeling for Bynfezia Pen (NDC 62756-452). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-octreotide-carton (Spl Octreotide Carton)

Box packaging label for BYNFEZIA Pen 2.5 mg/mL (octreotide acetate injection) by Sun Pharmaceutical Industries, Inc. The label indicates two 2.8 mL disposable single-patient-use prefilled pens for subcutaneous injection. The label includes dosing information for 50, 100, 150, and 200 mcg doses and storage instructions. It also notes that pen needles are not included.*

FDA Label Image

Spl-octreotide-figure1 (Spl Octreotide Figure1)

An instructional diagram detailing the parts of the BYNFEZIA Pen prefilled injection device containing octreotide acetate 2.5 mg/mL. It labels the needle components (outer needle cover, inner needle cover, paper tab) and pen components (pen cap, rubber seal, cartridge holder, pen label, dose display window, dose set knob, injection button) to help users identify each part of the subcutaneous injection pen.*

FDA Label Image

Spl-octreotide-figure10 (Spl Octreotide Figure10)

An instructional illustration showing a person removing or pulling off the top cap of a BYNFEZIA Pen injection device by grasping the cap with one hand and holding the pen body with the other. The green arrow indicates the direction of cap removal shown in Figure I.*

FDA Label Image

Spl-octreotide-figure11 (Spl Octreotide Figure11)

An instructional illustration showing a hand pulling a blue protective cap off a pen needle. The arrow points upward, indicating the cap removal direction. The word 'Save' is labeled near the cap, demonstrating part of the preparation process for using the BYNFEZIA Pen injection.*

FDA Label Image

Spl-octreotide-figure12 (Spl Octreotide Figure12)

Instructional diagram showing a hand removing a cap or cover from a syringe or injection device, with an upward arrow indicating the direction to throw away the cap. The image is labeled as Figure K, suggesting it is part of a sequence of steps for using the BYNFEZIA Pen injection.*

FDA Label Image

Spl-octreotide-figure13 (Spl Octreotide Figure13)

An instructional illustration showing a close-up of a hand adjusting a dose selector on the BYNFEZIA Pen injection device. The dose indicator highlights the number 100, with a green arrow pointing upward, indicating the direction to set the dose.*

FDA Label Image

Spl-octreotide-figure14 (Spl Octreotide Figure14)

An instructional illustration showing a hand holding a BYNFEZIA Pen injection device. It demonstrates the action of pushing the pen upwards, with a zoomed-in inset of the dose window displaying the number '0', indicating dose completion or readiness.*

FDA Label Image

Spl-octreotide-figure15 (Spl Octreotide Figure15)

An instructional diagram labeled Figure N showing a close-up of a needle with multiple fine, hair-like fibers extending from its tip, likely illustrating a specific needle feature or design detail for the BYNFEZIA Pen injection device.*

FDA Label Image

Spl-octreotide-figure16 (Spl Octreotide Figure16)

An illustration of a human torso and upper legs showing preferred subcutaneous injection sites for BYNFEZIA Pen (octreotide acetate). Highlighted areas in blue include the abdomen around the navel, outer upper arms, and front upper thighs.*

FDA Label Image

Spl-octreotide-figure17 (Spl Octreotide Figure17)

Illustration showing a hand holding a cotton swab or gauze pad pressing against skin, likely depicting an injection site preparation or post-injection care for subcutaneous administration.*

FDA Label Image

Spl-octreotide-figure18 (Spl Octreotide Figure18)

An instructional illustration showing a close-up of a finger pressing or lifting a pointer labeled '###' on a device, likely related to the BYNFEZIA Pen injection. The image emphasizes handling or operating the pointer component on the injection pen.*

FDA Label Image

Spl-octreotide-figure19 (Spl Octreotide Figure19)

Instructional diagram showing a hand holding the BYNFEZIA Pen injection device. An arrow points downward indicating the pen should be inserted at a right angle into the skin for subcutaneous injection, labeled as Figure R.*

FDA Label Image

Spl-octreotide-figure2 (Spl Octreotide Figure2)

An instructional illustration labeled 'Figure A' showing two hands being rinsed under running water from a faucet, demonstrating hand washing technique as part of an injection preparation or hygiene procedure.*

FDA Label Image

Spl-octreotide-figure20 (Spl Octreotide Figure20)

An instructional illustration showing a hand holding the BYNFEZIA Pen injection device, demonstrating the pressing action for subcutaneous administration. A close-up inset highlights the dose indicator on the pen, pointing to the number zero to confirm dose readiness.*

FDA Label Image

Spl-octreotide-figure21 (Spl Octreotide Figure21)

An instructional illustration showing a hand holding a BYNFEZIA Pen injection device with a green downward arrow, alongside a stopwatch graphic counting from 1 to 10 seconds. The image includes the word 'Hold' in a green box, indicating a step for holding the device after administration.*

FDA Label Image

Spl-octreotide-figure22 (Spl Octreotide Figure22)

Illustration showing a hand holding a BYNFEZIA Pen injection device with the instruction to lift the cap, indicated by a green arrow pointing upward. The syringe needle is visible at the bottom. The image is labeled as Figure U.*

FDA Label Image

Spl-octreotide-figure23 (Spl Octreotide Figure23)

An instructional diagram labeled as Figure V depicting the assembly or connection of parts for an injection device, showing a needle cap or cover being removed or attached with an arrow indicating direction.*

FDA Label Image

Spl-octreotide-figure24 (Spl Octreotide Figure24)

Illustration showing the removal of the protective cap from a BYNFEZIA Pen injection device. The left image shows a hand twisting the cap, and the right image shows the cap being lifted off the top of the pen, with upward arrows indicating the removal direction.*

FDA Label Image

Spl-octreotide-figure25 (Spl Octreotide Figure25)

An instructional illustration showing a hand holding a blue device or cap, inserting or removing it from a rectangular opening on top of a red container. The image appears to be part of a usage or handling guide for a medical or injection device.*

FDA Label Image

Spl-octreotide-figure26 (Spl Octreotide Figure26)

An instructional illustration showing a hand holding the BYNFEZIA Pen injection device while another hand is about to remove a blue cap from the top of the pen, indicated by a green arrow. This depicts a step in the preparation or usage process of the BYNFEZIA Pen octreotide acetate injection.*

FDA Label Image

Spl-octreotide-figure3 (Spl Octreotide Figure3)

The image shows a blue BYNFEZIA Pen for subcutaneous injection containing octreotide acetate 2.5 mg/mL. The pen has labels with barcode, lot number placeholder (LOT XXXXXXXX), and expiration date placeholder (EXP MMYYYY). The product is labeled by Sun Pharmaceutical Industries, Inc.*

FDA Label Image

Spl-octreotide-figure4 (Spl Octreotide Figure4)

An instructional illustration showing hands preparing an injection pen device, identified as Figure C. One hand holds the pen body while the other hand removes the cap from the pen in an upward motion. This diagram likely demonstrates a step in the administration or preparation of the BYNFEZIA Pen injection.*

FDA Label Image

Spl-octreotide-figure5 (Spl Octreotide Figure5)

An instructional illustration labeled Figure D, showing a person holding a BYNFEZIA Pen injection device near the eye with a green arrow pointing to the nose side, indicating the direction or angle for administration of the injection.*

FDA Label Image

Spl-octreotide-figure6 (Spl Octreotide Figure6)

An instructional illustration showing a hand holding a BYNFEZIA Pen injection device, highlighting the thick line indicator on the syringe barrel. The image appears to guide the user on how to read or align the injection dose for the octreotide acetate subcutaneous injection.*

FDA Label Image

Spl-octreotide-figure7 (Spl Octreotide Figure7)

Illustration shows four labeled items related to injection preparation: two alcohol swabs, a new pen needle, a sharps container, and a cotton ball. These visuals support proper use of the BYNFEZIA Pen injection.*

FDA Label Image

Spl-octreotide-figure8 (Spl Octreotide Figure8)

Illustration labeled Figure G showing a hand pouring a powdered medicine from a packet into a vial, demonstrating the preparation step for the BYNFEZIA Pen injection.*

FDA Label Image

Spl-octreotide-figure9 (Spl Octreotide Figure9)

An instructional illustration labeled Figure H showing a hand peeling off a yellow protective cap from a small medical device, presumably part of the BYNFEZIA Pen injection device used for subcutaneous administration.*

FDA Label Image

Spl-octreotide-structure.jpg (Spl Octreotide Structure)

Chemical structure description of octreotide acetate showing its amino acid sequence and the variable 'x' indicating the acetate group range from 1.4 to 2.5.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.